636 related articles for article (PubMed ID: 19204403)
1. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1.
Naito T; Masaki T; Nikolic-Paterson DJ; Tanji C; Yorioka N; Kohno N
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F278-87. PubMed ID: 14583433
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin synthesis by high glucose level mediated proliferation of mouse embryonic stem cells: Involvement of ANG II and TGF-beta1.
Kim YH; Ryu JM; Lee YJ; Han HJ
J Cell Physiol; 2010 May; 223(2):397-407. PubMed ID: 20112290
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
Zhang SQ; Ding B; Guo ZG; Li YX
Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
[TBL] [Abstract][Full Text] [Related]
7. Role of Ras in ethanol modulation of angiotensin II activated p42/p44 MAP kinase in rat hepatocytes.
Park PH; Aroor AR; Shukla SD
Life Sci; 2006 Nov; 79(25):2357-63. PubMed ID: 16950409
[TBL] [Abstract][Full Text] [Related]
8. Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells.
Sharma K; Deelman L; Madesh M; Kurz B; Ciccone E; Siva S; Hu T; Zhu Y; Wang L; Henning R; Ma X; Hajnoczky G
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1258-70. PubMed ID: 12876066
[TBL] [Abstract][Full Text] [Related]
9. Ethanol abrogates angiotensin II-stimulated vascular smooth muscle cell growth.
Cain ML; Hester RL; Izevbigie EB
Med Sci Monit; 2006 May; 12(5):BR162-8. PubMed ID: 16641869
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells.
Kim YM; Jeon ES; Kim MR; Jho SK; Ryu SW; Kim JH
Int J Biochem Cell Biol; 2008; 40(11):2482-91. PubMed ID: 18571460
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
Song CY; Kim BC; Lee HS
Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
[TBL] [Abstract][Full Text] [Related]
12. Novel protein kinase C-epsilon inhibits human CYP11B2 gene expression through ERK1/2 signalling pathway and JunB.
LeHoux JG; Lefebvre A
J Mol Endocrinol; 2006 Feb; 36(1):51-64. PubMed ID: 16461926
[TBL] [Abstract][Full Text] [Related]
13. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
[TBL] [Abstract][Full Text] [Related]
14. Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells.
Imanishi T; Hano T; Nishio I
Hypertens Res; 2005 Mar; 28(3):263-71. PubMed ID: 16097371
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia.
Weigert C; Brodbeck K; Klopfer K; Häring HU; Schleicher ED
Diabetologia; 2002 Jun; 45(6):890-8. PubMed ID: 12107734
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells.
Lavrentyev EN; Estes AM; Malik KU
Circ Res; 2007 Aug; 101(5):455-64. PubMed ID: 17626897
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1 impairs endothelin-1-mediated contraction of brain vessels by inducing mitogen-activated protein (MAP) kinase phosphatase-1 and inhibiting p38 MAP kinase.
Tong XK; Hamel E
Mol Pharmacol; 2007 Dec; 72(6):1476-83. PubMed ID: 17848599
[TBL] [Abstract][Full Text] [Related]
18. All-trans retinoic acid inhibits the increases in fibronectin and PAI-1 induced by TGF-beta1 and Ang II in rat mesangial cells.
Liu X; Lü L; Tao BB; Zhu YC
Acta Pharmacol Sin; 2008 Sep; 29(9):1035-41. PubMed ID: 18718172
[TBL] [Abstract][Full Text] [Related]
19. Nicotine enhances angiotensin II-induced mitogenic response in vascular smooth muscle cells and fibroblasts.
Li JM; Cui TX; Shiuchi T; Liu HW; Min LJ; Okumura M; Jinno T; Wu L; Iwai M; Horiuchi M
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):80-4. PubMed ID: 14592853
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
